New algorithms for treating homozygous familial hypercholesterolemia.
Journal Information
Full Title: Curr Opin Lipidol
Abbreviation: Curr Opin Lipidol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Conflicts of interest T.R.T. declares no conflicts of interest. M.C. reports institutional support for the conduction of clinical trials from Regeneron Pharmaceuticals and Regenxbio; consulting fees from Amryt Pharma. T.R.T. declares no conflicts of interest. M.C. reports institutional support for the conduction of clinical trials from Regeneron Pharmaceuticals and Regenxbio; consulting fees from Amryt Pharma."
Funding Disclosure
Evidence found in paper:
"Financial support and sponsorship None."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025